{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:05:22Z","timestamp":1785769522990,"version":"3.56.0"},"reference-count":145,"publisher":"Elsevier","isbn-type":[{"value":"9780323988513","type":"print"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/bs.acc.2022.03.001","type":"book-chapter","created":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T21:00:24Z","timestamp":1657659624000},"page":"1-30","source":"Crossref","is-referenced-by-count":49,"title":["Biomarkers of dysfunctional visceral fat"],"prefix":"10.1016","member":"78","reference":[{"issue":"2","key":"10.1016\/bs.acc.2022.03.001_bb0010","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00041552-200403000-00010","article-title":"Leptin, obesity and cardiovascular disease","volume":"13","author":"Correia","year":"2004","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"3","key":"10.1016\/bs.acc.2022.03.001_bb0015","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/(SICI)1098-1128(199705)17:3<225::AID-MED1>3.0.CO;2-#","article-title":"Leptin","volume":"17","author":"Remesar","year":"1997","journal-title":"Med. Res. Rev."},{"issue":"6","key":"10.1016\/bs.acc.2022.03.001_bb0020","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/22953337.1996.11718534","article-title":"Lessons from the discovery of leptin: is obesity an endocrine disease?","volume":"51","author":"Scheen","year":"1996","journal-title":"Acta Clin. Belg."},{"issue":"2","key":"10.1016\/bs.acc.2022.03.001_bb0025","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/jmcb\/mjw011","article-title":"Adiponectin, the past two decades","volume":"8","author":"Wang","year":"2016","journal-title":"J. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/bs.acc.2022.03.001_bb0030","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1161\/CIRCRESAHA.120.314458","article-title":"Adiponectin, leptin and cardiovascular disorders","volume":"128","author":"Zhao","year":"2021","journal-title":"Circ. Res."},{"issue":"5676","key":"10.1016\/bs.acc.2022.03.001_bb0035","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1126\/science.304.5676.1413","article-title":"The obesity epidemic","volume":"304","author":"Abelson","year":"2004","journal-title":"Science"},{"issue":"8832","key":"10.1016\/bs.acc.2022.03.001_bb0040","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/0140-6736(92)92616-N","article-title":"Pathophysiology of obesity","volume":"340","author":"Kennedy","year":"1992","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/bs.acc.2022.03.001_bb0045","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1210\/jcem-9-3-275","article-title":"Results of prolonged medical treatment of obesity with diet alone, diet and thyroid preparations, and diet and amphetamine","volume":"9","author":"Adlersberg","year":"1949","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/bs.acc.2022.03.001_bb0050","first-page":"43","article-title":"The glucostatic theory of regulation of food intake and the problem of obesity","volume":"14","author":"Mayer","year":"1952","journal-title":"Bull. New Engl. Med. Cent."},{"issue":"3","key":"10.1016\/bs.acc.2022.03.001_bb0055","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0002-8223(21)23381-6","article-title":"An experimentalist's approach to the problem of obesity","volume":"31","author":"Mayer","year":"1955","journal-title":"J. Am. Diet. Assoc."},{"issue":"3","key":"10.1016\/bs.acc.2022.03.001_bb0060","first-page":"501","article-title":"Fat metabolism in three forms of obesity. V. Hepatic lipogenesis in vitro","volume":"181","author":"Mayer","year":"1955","journal-title":"Am. J. Phys."},{"issue":"3081","key":"10.1016\/bs.acc.2022.03.001_bb0065","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1126\/science.119.3081.96","article-title":"The multiple etiology of obesity: production of two types of obesity in littermate mice","volume":"119","author":"Mayer","year":"1954","journal-title":"Science"},{"issue":"1","key":"10.1016\/bs.acc.2022.03.001_bb0070","first-page":"28","article-title":"An approach to the problem of obesity","volume":"52","author":"Bray","year":"1969","journal-title":"R I Med. J."},{"issue":"1","key":"10.1016\/bs.acc.2022.03.001_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0011-5029(79)80003-6","article-title":"Obesity","volume":"26","author":"Bray","year":"1979","journal-title":"Dis. Mon."},{"issue":"1","key":"10.1016\/bs.acc.2022.03.001_bb0080","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1249\/00005768-198315010-00008","article-title":"The energetics of obesity","volume":"15","author":"Bray","year":"1983","journal-title":"Med. Sci. Sports Exerc."},{"issue":"Suppl. 2","key":"10.1016\/bs.acc.2022.03.001_bb0085","doi-asserted-by":"crossref","first-page":"488S","DOI":"10.1093\/ajcn\/55.2.488s","article-title":"Pathophysiology of obesity","volume":"55","author":"Bray","year":"1992","journal-title":"Am. J. Clin. Nutr."},{"issue":"Suppl. 4","key":"10.1016\/bs.acc.2022.03.001_bb0090","first-page":"21","article-title":"Nutrition and obesity: prevention and treatment","volume":"9","author":"Bray","year":"1999","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"issue":"12","key":"10.1016\/bs.acc.2022.03.001_bb0095","first-page":"1406","article-title":"Let's treat obesity seriously","volume":"81","author":"Bray","year":"2010","journal-title":"Am. Fam. Physician"},{"issue":"1","key":"10.1016\/bs.acc.2022.03.001_bb0100","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/MOL.0b013e3283346ca2","article-title":"Soft drink consumption and obesity: it is all about fructose","volume":"21","author":"Bray","year":"2010","journal-title":"Curr. Opin. Lipidol."},{"issue":"2","key":"10.1016\/bs.acc.2022.03.001_bb0105","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1210\/er.2017-00253","article-title":"The science of obesity management: An Endocrine Society scientific statement","volume":"39","author":"Bray","year":"2018","journal-title":"Endocr. Rev."},{"issue":"7","key":"10.1016\/bs.acc.2022.03.001_bb0110","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/nrd4671","article-title":"Obesity: reversing resistance to leptin in obesity","volume":"14","author":"Bray","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/bs.acc.2022.03.001_bb0115","first-page":"1","article-title":"The age of obesity","volume":"1","author":"Howard","year":"1977","journal-title":"Int. J. Obes."},{"issue":"Suppl","key":"10.1016\/bs.acc.2022.03.001_bb0120","doi-asserted-by":"crossref","first-page":"S395","DOI":"10.1194\/jlr.R800057-JLR200","article-title":"Adipocyte metabolism and obesity","volume":"50","author":"Attie","year":"2009","journal-title":"J. Lipid Res."},{"issue":"3","key":"10.1016\/bs.acc.2022.03.001_bb0125","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.coph.2004.03.003","article-title":"The delicate balance between fat and muscle: adipokines in metabolic disease and musculoskeletal inflammation","volume":"4","author":"Nawrocki","year":"2004","journal-title":"Curr. Opin. Pharmacol."},{"issue":"11","key":"10.1016\/bs.acc.2022.03.001_bb0130","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1161\/CIRCRESAHA.116.308999","article-title":"Obesity, diabetes, and cardiovascular diseases: a compendium","volume":"118","author":"Scherer","year":"2016","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/bs.acc.2022.03.001_bb0135","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s42255-019-0041-z","article-title":"Metabolic messengers: adiponectin","volume":"1","author":"Straub","year":"2019","journal-title":"Nat. Metab."},{"issue":"5","key":"10.1016\/bs.acc.2022.03.001_bb0140","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1210\/jc.2007-2191","article-title":"Visceral obesity and plasma glucose-insulin homeostasis: contributions of interleukin-6 and tumor necrosis factor-alpha in men","volume":"93","author":"Cartier","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/bs.acc.2022.03.001_bb0145","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/07853890500383895","article-title":"Is visceral obesity the cause of the metabolic syndrome?","volume":"38","author":"Despres","year":"2006","journal-title":"Ann. Med."},{"issue":"19","key":"10.1016\/bs.acc.2022.03.001_bb0150","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/j.jacc.2010.10.063","article-title":"Excess visceral adipose tissue\/ectopic fat the missing link in the obesity paradox?","volume":"57","author":"Despres","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9","key":"10.1016\/bs.acc.2022.03.001_bb0155","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S2213-8587(19)30084-1","article-title":"Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement","volume":"7","author":"Neeland","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"3","key":"10.1016\/bs.acc.2022.03.001_bb0160","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41574-019-0310-7","article-title":"Waist circumference as a vital sign in clinical practice: a consensus statement from the IAS and ICCR working group on visceral obesity","volume":"16","author":"Ross","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"issue":"1","key":"10.1016\/bs.acc.2022.03.001_bb0165","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1152\/physrev.00033.2011","article-title":"Pathophysiology of human visceral obesity: an update","volume":"93","author":"Tchernof","year":"2013","journal-title":"Physiol. Rev."},{"key":"10.1016\/bs.acc.2022.03.001_bb0170","first-page":"271","article-title":"Visceral obesity, insulin resistance, and dyslipidemia: contribution of endurance exercise training to the treatment of the plurimetabolic syndrome","volume":"25","author":"Despres","year":"1997","journal-title":"Exerc. Sport Sci. Rev."},{"issue":"8","key":"10.1016\/bs.acc.2022.03.001_bb0175","doi-asserted-by":"crossref","first-page":"534","DOI":"10.3109\/07853890108995963","article-title":"Health consequences of visceral obesity","volume":"33","author":"Despres","year":"2001","journal-title":"Ann. Med."},{"issue":"2","key":"10.1016\/bs.acc.2022.03.001_bb0180","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/HPC.0b013e318057d4c9","article-title":"Cardiovascular disease under the influence of excess visceral fat","volume":"6","author":"Despres","year":"2007","journal-title":"Crit. Pathw. Cardiol."},{"issue":"4","key":"10.1016\/bs.acc.2022.03.001_bb0185","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11154-014-9299-3","article-title":"Ectopic visceral fat: a clinical and molecular perspective on the cardiometabolic risk","volume":"15","author":"Mathieu","year":"2014","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/bs.acc.2022.03.001_bb0190","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cca.2020.05.014","article-title":"Higher ANGPTL3, apoC-III, and apoB48 dyslipidemia, and lower lipoprotein lipase concentrations are associated with dysfunctional visceral fat in adolescents with obesity","volume":"508","author":"Rodriguez-Mortera","year":"2020","journal-title":"Clin. Chim. Acta"},{"issue":"6","key":"10.1016\/bs.acc.2022.03.001_bb0195","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2337\/diacare.19.6.629","article-title":"The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men","volume":"19","author":"Tchernof","year":"1996","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/bs.acc.2022.03.001_bb0200","doi-asserted-by":"crossref","first-page":"953","DOI":"10.2337\/diabetes.47.6.953","article-title":"Postprandial triglyceride response in visceral obesity in men","volume":"47","author":"Couillard","year":"1998","journal-title":"Diabetes"},{"issue":"Suppl. 2","key":"10.1016\/bs.acc.2022.03.001_bb0205","first-page":"45","article-title":"Lipoprotein metabolism in visceral obesity","volume":"15","author":"Despres","year":"1991","journal-title":"Int. J. Obes."},{"issue":"4","key":"10.1016\/bs.acc.2022.03.001_bb0210","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1161\/HYPERTENSIONAHA.108.110320","article-title":"Visceral obesity: the link among inflammation, hypertension, and cardiovascular disease","volume":"53","author":"Mathieu","year":"2009","journal-title":"Hypertension"},{"issue":"8","key":"10.1016\/bs.acc.2022.03.001_bb0215","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008139","article-title":"Hypertriglyceridemic waist: a simple marker of high-risk atherosclerosis features associated with excess visceral adiposity\/ectopic fat","volume":"7","author":"LeBlanc","year":"2018","journal-title":"J. Am. Heart Assoc."},{"issue":"3","key":"10.1016\/bs.acc.2022.03.001_bb0220","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00008483-200305000-00001","article-title":"Waist circumference, visceral obesity, and cardiovascular risk","volume":"23","author":"Poirier","year":"2003","journal-title":"J. Cardpulm. Rehabil."},{"key":"10.1016\/bs.acc.2022.03.001_bb0225","doi-asserted-by":"crossref","DOI":"10.1038\/s41366-021-00854-x","article-title":"Untargeted metabolomics reveals plasma metabolites predictive of ectopic fat in pancreas and liver as assessed by magnetic resonance imaging: the TOFI_Asia study","author":"Wu","year":"2021","journal-title":"Int. J. Obes."},{"issue":"1","key":"10.1016\/bs.acc.2022.03.001_bb0230","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12986-020-00518-z","article-title":"Metabolomic signatures for visceral adiposity and dysglycaemia in Asian Chinese and Caucasian European adults: the cross-sectional TOFI_Asia study","volume":"17","author":"Wu","year":"2020","journal-title":"Nutr. Metab. (Lond.)"},{"issue":"2","key":"10.1016\/bs.acc.2022.03.001_bb0235","doi-asserted-by":"crossref","first-page":"96","DOI":"10.18544\/PEDM-23.02.0079","article-title":"TOFI phenotype\u2014its effect on the occurrence of diabetes","volume":"23","author":"Zdrojewicz","year":"2017","journal-title":"Pediatr. Endocrinol. Diabetes Metab."},{"issue":"1","key":"10.1016\/bs.acc.2022.03.001_bb0240","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1172\/JCI88883","article-title":"The ominous triad of adipose tissue dysfunction: inflammation, fibrosis, and impaired angiogenesis","volume":"127","author":"Crewe","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/bs.acc.2022.03.001_bb0245","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.569250","article-title":"The role of ceramides in diabetes and cardiovascular disease regulation of ceramides by Adipokines","volume":"11","author":"Field","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"10.1016\/bs.acc.2022.03.001_bb0250","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1146\/annurev-immunol-031210-101322","article-title":"Inflammatory mechanisms in obesity","volume":"29","author":"Gregor","year":"2011","journal-title":"Annu. Rev. Immunol."},{"issue":"Suppl. 7","key":"10.1016\/bs.acc.2022.03.001_bb0255","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1038\/ijo.2008.238","article-title":"Inflammation and endoplasmic reticulum stress in obesity and diabetes","volume":"32","author":"Hotamisligil","year":"2008","journal-title":"Int. J. Obes."},{"issue":"3","key":"10.1016\/bs.acc.2022.03.001_bb0260","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.immuni.2017.08.009","article-title":"Foundations of Immunometabolism and implications for metabolic health and disease","volume":"47","author":"Hotamisligil","year":"2017","journal-title":"Immunity"},{"issue":"7640","key":"10.1016\/bs.acc.2022.03.001_bb0265","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature21363","article-title":"Inflammation, metaflammation and immunometabolic disorders","volume":"542","author":"Hotamisligil","year":"2017","journal-title":"Nature"},{"issue":"11","key":"10.1016\/bs.acc.2022.03.001_bb0270","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.2337\/diab.43.11.1271","article-title":"Tumor necrosis factor alpha: a key component of the obesity-diabetes link","volume":"43","author":"Hotamisligil","year":"1994","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/bs.acc.2022.03.001_bb0275","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/0092-8674(93)90243-J","article-title":"Through thick and thin: wasting, obesity, and TNF alpha","volume":"73","author":"Spiegelman","year":"1993","journal-title":"Cell"},{"issue":"2","key":"10.1016\/bs.acc.2022.03.001_bb0280","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1158\/1940-6207.CAPR-17-0245","article-title":"Macrophagic \u201ccrown-like structures\u201d are associated with an increased risk of breast Cancer in benign breast disease","volume":"11","author":"Carter","year":"2018","journal-title":"Cancer Prev. Res. (Phila.)"},{"issue":"3","key":"10.1016\/bs.acc.2022.03.001_bb0285","doi-asserted-by":"crossref","first-page":"233","DOI":"10.4048\/jbc.2020.23.e35","article-title":"Obesity and breast cancer: the role of crown-like structures in breast adipose tissue in tumor progression, prognosis, and therapy","volume":"23","author":"Faria","year":"2020","journal-title":"J. Breast Cancer"},{"issue":"5","key":"10.1016\/bs.acc.2022.03.001_bb0290","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1054\/mehy.1997.0684","article-title":"Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: down-regulation with essential fatty acids, ethanol and pentoxifylline","volume":"52","author":"McCarty","year":"1999","journal-title":"Med. Hypotheses"},{"key":"10.1016\/bs.acc.2022.03.001_bb0295","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.coph.2020.04.010","article-title":"Recent advances in the role of interleukin-6 in health and disease","volume":"52","author":"Peppler","year":"2020","journal-title":"Curr. Opin. Pharmacol."},{"issue":"5 Suppl. 1","key":"10.1016\/bs.acc.2022.03.001_bb0300","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.amjmed.2006.01.009","article-title":"Etiology of insulin resistance","volume":"119","author":"Petersen","year":"2006","journal-title":"Am. J. Med."},{"issue":"3","key":"10.1016\/bs.acc.2022.03.001_bb0305","doi-asserted-by":"crossref","first-page":"E548","DOI":"10.1152\/ajpendo.00251.2020","article-title":"Visceral adiposity and liver fat as mediators of the association between cardiorespiratory fitness and plasma glucose-insulin homeostasis","volume":"319","author":"Chartrand","year":"2020","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"Suppl. 1","key":"10.1016\/bs.acc.2022.03.001_bb0310","first-page":"8S","article-title":"The insulin resistance-dyslipidemic syndrome of visceral obesity: effect on patients' risk","volume":"6","author":"Despres","year":"1998","journal-title":"Obes. Res."},{"issue":"5","key":"10.1016\/bs.acc.2022.03.001_bb0315","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/j.1550-8528.1997.tb00664.x","article-title":"Segregation analysis of abdominal visceral fat: the HERITAGE family study","volume":"5","author":"Rice","year":"1997","journal-title":"Obes. Res."},{"issue":"1","key":"10.1016\/bs.acc.2022.03.001_bb0320","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1600-065X.2012.01145.x","article-title":"Inflammation links excess fat to insulin resistance: the role of the interleukin-1 family","volume":"249","author":"Tack","year":"2012","journal-title":"Immunol. Rev."},{"issue":"Suppl. 3","key":"10.1016\/bs.acc.2022.03.001_bb0325","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1046\/j.1365-2362.32.s3.3.x","article-title":"Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction","volume":"32","author":"Boden","year":"2002","journal-title":"Eur. J. Clin. Investig."},{"issue":"7","key":"10.1016\/bs.acc.2022.03.001_bb0330","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.tips.2017.04.004","article-title":"Roles of diacylglycerols and ceramides in hepatic insulin resistance","volume":"38","author":"Petersen","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"issue":"9733","key":"10.1016\/bs.acc.2022.03.001_bb0335","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1016\/S0140-6736(10)60408-4","article-title":"Lipid-induced insulin resistance: unravelling the mechanism","volume":"375","author":"Samuel","year":"2010","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/bs.acc.2022.03.001_bb0340","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1152\/physrev.00024.2006","article-title":"Disordered lipid metabolism and the pathogenesis of insulin resistance","volume":"87","author":"Savage","year":"2007","journal-title":"Physiol. Rev."},{"issue":"1A","key":"10.1016\/bs.acc.2022.03.001_bb0345","doi-asserted-by":"crossref","first-page":"3J","DOI":"10.1016\/S0002-9149(99)00350-1","article-title":"Cellular mechanisms of insulin resistance in humans","volume":"84","author":"Shulman","year":"1999","journal-title":"Am. J. Cardiol."},{"issue":"5","key":"10.1016\/bs.acc.2022.03.001_bb0350","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1007\/s00125-021-05415-5","article-title":"Defining the underlying defect in insulin action in type 2 diabetes","volume":"64","author":"Batista","year":"2021","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/bs.acc.2022.03.001_bb0355","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF02048541","article-title":"Insulin receptor\/IRS-1\/PI 3-kinase signaling system in corticosteroid-induced insulin resistance","volume":"33","author":"Folli","year":"1996","journal-title":"Acta Diabetol."},{"issue":"8","key":"10.1016\/bs.acc.2022.03.001_bb0360","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.2337\/diab.43.8.1066","article-title":"Banting Lecture. Insulin action, diabetogenes, and the cause of type II diabetes","volume":"43","author":"Kahn","year":"1994","journal-title":"Diabetes"},{"key":"10.1016\/bs.acc.2022.03.001_bb0365","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1146\/annurev.physiol.65.092101.142540","article-title":"Insulin receptor knockout mice","volume":"65","author":"Kitamura","year":"2003","journal-title":"Annu. Rev. Physiol."},{"issue":"2","key":"10.1016\/bs.acc.2022.03.001_bb0370","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrm1837","article-title":"Critical nodes in signalling pathways: insights into insulin action","volume":"7","author":"Taniguchi","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/bs.acc.2022.03.001_bb0375","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1172\/JCI77812","article-title":"The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux","volume":"126","author":"Samuel","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/bs.acc.2022.03.001_bb0380","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1210\/jc.2004-1711","article-title":"Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men","volume":"90","author":"Cote","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/bs.acc.2022.03.001_bb0385","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.beem.2005.07.008","article-title":"Adipocytokines: leptin\u2014the classical, resistin\u2014the controversical, adiponectin\u2014the promising, and more to come","volume":"19","author":"Koerner","year":"2005","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/bs.acc.2022.03.001_bb0390","article-title":"Adiponectin preserves metabolic fitness during aging","volume":"10","author":"Li","year":"2021","journal-title":"elife"},{"issue":"5","key":"10.1016\/bs.acc.2022.03.001_bb0395","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.cell.2012.02.017","article-title":"Mechanisms for insulin resistance: common threads and missing links","volume":"148","author":"Samuel","year":"2012","journal-title":"Cell"},{"issue":"2","key":"10.1016\/bs.acc.2022.03.001_bb0400","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S1043-2760(01)00524-0","article-title":"ACRP30\/adiponectin: an adipokine regulating glucose and lipid metabolism","volume":"13","author":"Berg","year":"2002","journal-title":"Trends Endocrinol. Metab."},{"issue":"1","key":"10.1016\/bs.acc.2022.03.001_bb0405","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/HYPERTENSIONAHA.107.099424","article-title":"Adiponectin, cardiovascular function, and hypertension","volume":"51","author":"Wang","year":"2008","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/bs.acc.2022.03.001_bb0410","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1161\/CIRCRESAHA.116.309226","article-title":"Adiponectin: just along for the ride?","volume":"119","author":"Turer","year":"2016","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/bs.acc.2022.03.001_bb0415","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/01.mol.0000217899.59820.9a","article-title":"Resistin","volume":"17","author":"McTernan","year":"2006","journal-title":"Curr. Opin. Lipidol."},{"issue":"4","key":"10.1016\/bs.acc.2022.03.001_bb0420","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1123\/pes.2014-0072","article-title":"Adiponectin, resistin, and visfatin in childhood obesity and exercise","volume":"27","author":"Jamurtas","year":"2015","journal-title":"Pediatr. Exerc. Sci."},{"issue":"19","key":"10.1016\/bs.acc.2022.03.001_bb0425","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1093\/eurheartj\/ehl248","article-title":"Adiponectin and myocardial infarction: a paradox or a paradigm?","volume":"27","author":"Teoh","year":"2006","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/bs.acc.2022.03.001_bb0430","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1042\/BJ20082033","article-title":"Adiponectin: no longer the lone soul in the fight against insulin resistance?","volume":"416","author":"Davis","year":"2008","journal-title":"Biochem. J."},{"issue":"9","key":"10.1016\/bs.acc.2022.03.001_bb0435","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1210\/jc.2008-1435","article-title":"Adiponectin, diabetes, and coronary heart disease in older persons: unraveling the paradox","volume":"93","author":"Sattar","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/bs.acc.2022.03.001_bb0440","first-page":"381","article-title":"Obesity paradox\u2014the controversial role of body mass index and plasma adiponectin in coronary artery disease and acute coronary syndrome","volume":"29","author":"Lin","year":"2013","journal-title":"Acta Cardiol. Sin."},{"issue":"3","key":"10.1016\/bs.acc.2022.03.001_bb0445","doi-asserted-by":"crossref","first-page":"292","DOI":"10.5551\/jat.ED031","article-title":"Another paradox regarding adiponectin revisited","volume":"23","author":"Gotoda","year":"2016","journal-title":"J. Atheroscler. Thromb."},{"issue":"1","key":"10.1016\/bs.acc.2022.03.001_bb0450","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2337\/dbi17-0016","article-title":"The adiponectin paradox for all-cause and cardiovascular mortality","volume":"67","author":"Menzaghi","year":"2018","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/bs.acc.2022.03.001_bb0455","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/S0960-9822(95)00264-8","article-title":"Appetite control: does leptin lighten the problem of obesity?","volume":"5","author":"McGarry","year":"1995","journal-title":"Curr. Biol."},{"issue":"9","key":"10.1016\/bs.acc.2022.03.001_bb0460","first-page":"540","article-title":"Leptin, its receptor and obesity","volume":"44","author":"Misra","year":"1996","journal-title":"J. Investig. Med."},{"issue":"Suppl. 4","key":"10.1016\/bs.acc.2022.03.001_bb0465","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1038\/sj.ijo.0801497","article-title":"Molecular mechanisms of insulin resistance and the role of the adipocyte","volume":"24","author":"Hotamisligil","year":"2000","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"issue":"4","key":"10.1016\/bs.acc.2022.03.001_bb0470","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1556\/2060.2020.00038","article-title":"Leptin and obesity","volume":"107","author":"Seth","year":"2020","journal-title":"Physiol. Int."},{"issue":"5","key":"10.1016\/bs.acc.2022.03.001_bb0475","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191593","article-title":"The pleiotropic roles of leptin in metabolism, immunity, and cancer","volume":"218","author":"de Candia","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/bs.acc.2022.03.001_bb0480","series-title":"Physiology. Leptin","author":"Dornbush","year":"2021"},{"issue":"Suppl. 5","key":"10.1016\/bs.acc.2022.03.001_bb0485","first-page":"254S","article-title":"Leptin resistance and obesity","volume":"14","author":"Enriori","year":"2006","journal-title":"Obesity (Silver Spring)"},{"issue":"12","key":"10.1016\/bs.acc.2022.03.001_bb0490","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1172\/JCI91578","article-title":"The long road to leptin","volume":"126","author":"Friedman","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/bs.acc.2022.03.001_bb0495","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/j.2040-4603.2018.tb00002.x","article-title":"Leptin function and regulation","volume":"8","author":"Zhang","year":"2017","journal-title":"Compr. Physiol."},{"key":"10.1016\/bs.acc.2022.03.001_bb0500","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-981-13-1286-1_8","article-title":"The leptin resistance","volume":"1090","author":"Liu","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/bs.acc.2022.03.001_bb0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2019.154735","article-title":"Leptin as a predictive marker for metabolic syndrome","volume":"121","author":"Ghadge","year":"2019","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/bs.acc.2022.03.001_bb0510","doi-asserted-by":"crossref","first-page":"T9","DOI":"10.1530\/JOE-14-0264","article-title":"20 years of leptin: insights into signaling assemblies of the leptin receptor","volume":"223","author":"Peelman","year":"2014","journal-title":"J. Endocrinol."},{"issue":"1","key":"10.1016\/bs.acc.2022.03.001_bb0515","doi-asserted-by":"crossref","first-page":"T83","DOI":"10.1530\/JOE-14-0358","article-title":"20 years of leptin: role of leptin in energy homeostasis in humans","volume":"223","author":"Rosenbaum","year":"2014","journal-title":"J. Endocrinol."},{"issue":"3","key":"10.1016\/bs.acc.2022.03.001_bb0520","doi-asserted-by":"crossref","first-page":"R81","DOI":"10.1530\/JOE-18-0606","article-title":"Leptin resensitisation: a reversion of leptin-resistant states","volume":"241","author":"Andreoli","year":"2019","journal-title":"J. Endocrinol."},{"issue":"8","key":"10.1016\/bs.acc.2022.03.001_bb0525","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/ncpendmet0220","article-title":"Childhood obesity: behavioral aberration or biochemical drive? Reinterpreting the first law of thermodynamics","volume":"2","author":"Lustig","year":"2006","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/bs.acc.2022.03.001_bb0530","first-page":"265","article-title":"The adiponectin to leptin ratio, a still unrecognized biomarker of insulin resistance and cardiometabolic risk","volume":"78","author":"Vatier","year":"2020","journal-title":"Ann. Biol. Clin. (Paris)"},{"issue":"9","key":"10.1016\/bs.acc.2022.03.001_bb0535","doi-asserted-by":"crossref","first-page":"2464S","DOI":"10.1093\/jn\/134.9.2464S","article-title":"Fatty acid binding proteins\u2014the evolutionary crossroads of inflammatory and metabolic responses","volume":"134","author":"Makowski","year":"2004","journal-title":"J. Nutr."},{"issue":"6","key":"10.1016\/bs.acc.2022.03.001_bb0540","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrd2589","article-title":"Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets","volume":"7","author":"Furuhashi","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/bs.acc.2022.03.001_bb0545","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053626","article-title":"Interleukin-1beta regulates fat-liver crosstalk in obesity by auto-paracrine modulation of adipose tissue inflammation and expandability","volume":"8","author":"Nov","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/bs.acc.2022.03.001_bb0550","doi-asserted-by":"crossref","first-page":"900","DOI":"10.2337\/db13-0436","article-title":"FABP4 attenuates PPARgamma and adipogenesis and is inversely correlated with PPARgamma in adipose tissues","volume":"63","author":"Garin-Shkolnik","year":"2014","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/bs.acc.2022.03.001_bb0555","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s11883-007-0023-6","article-title":"Adipocyte\/macrophage fatty acid binding proteins in metabolic syndrome","volume":"9","author":"Erbay","year":"2007","journal-title":"Curr. Atheroscler. Rep."},{"issue":"11","key":"10.1016\/bs.acc.2022.03.001_bb0560","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027356","article-title":"Serum fatty acid-binding protein 4 is a predictor of cardiovascular events in end-stage renal disease","volume":"6","author":"Furuhashi","year":"2011","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/bs.acc.2022.03.001_bb0565","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079386","article-title":"A critical role of fatty acid binding protein 4 and 5 (FABP4\/5) in the systemic response to fasting","volume":"8","author":"Syamsunarno","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/bs.acc.2022.03.001_bb0570","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1194\/jlr.S091793","article-title":"Adipokine FABP4 integrates energy stores and counterregulatory metabolic responses","volume":"60","author":"Prentice","year":"2019","journal-title":"J. Lipid Res."},{"key":"10.1016\/bs.acc.2022.03.001_bb0575","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.ejmech.2017.07.022","article-title":"Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. A comprehensive systematic review","volume":"138","author":"Floresta","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"18","key":"10.1016\/bs.acc.2022.03.001_bb0580","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.1016\/j.bmc.2016.07.022","article-title":"The discovery of novel and selective fatty acid binding protein 4 inhibitors by virtual screening and biological evaluation","volume":"24","author":"Zhou","year":"2016","journal-title":"Bioorg. Med. Chem."},{"issue":"4","key":"10.1016\/bs.acc.2022.03.001_bb0585","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1046\/j.1365-2265.2001.01377.x","article-title":"Resistin: a new link between obesity and insulin resistance?","volume":"55","author":"Vidal-Puig","year":"2001","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/bs.acc.2022.03.001_bb0590","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cca.2020.11.010","article-title":"Resistin: potential biomarker and therapeutic target in atherosclerosis","volume":"512","author":"Zhou","year":"2021","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/bs.acc.2022.03.001_bb0595","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.mad.2019.01.004","article-title":"Resistin: a reappraisal","volume":"178","author":"Acquarone","year":"2019","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/bs.acc.2022.03.001_bb0600","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.639417","article-title":"Cardiovascular and metabolic crosstalk in the brain: leptin and resistin","volume":"12","author":"Badoer","year":"2021","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/bs.acc.2022.03.001_bb0605","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1540\/jsmr.48.27","article-title":"Human resistin in cardiovascular disease","volume":"48","author":"Lee","year":"2012","journal-title":"J. Smooth Muscle Res."},{"issue":"18","key":"10.1016\/bs.acc.2022.03.001_bb0610","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJM200111013451814","article-title":"Resistin, obesity, and insulin resistance\u2014the emerging role of the adipocyte as an endocrine organ","volume":"345","author":"Shuldiner","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/bs.acc.2022.03.001_bb0615","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/oby.2002.162","article-title":"Resistin and adiponectin\u2014of mice and men","volume":"10","author":"Stumvoll","year":"2002","journal-title":"Obes. Res."},{"issue":"5","key":"10.1016\/bs.acc.2022.03.001_bb0620","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1530\/eje.0.1470571","article-title":"Resistin\u2014a mediator of obesity-associated insulin resistance or an innocent bystander?","volume":"147","author":"Ukkola","year":"2002","journal-title":"Eur. J. Endocrinol."},{"issue":"15","key":"10.1016\/bs.acc.2022.03.001_bb0625","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1111\/febs.15322","article-title":"Resistin in metabolism, inflammation, and disease","volume":"287","author":"Tripathi","year":"2020","journal-title":"FEBS J."},{"issue":"Suppl. 1","key":"10.1016\/bs.acc.2022.03.001_bb0630","first-page":"78","article-title":"Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity","volume":"32","author":"Juhan-Vague","year":"2000","journal-title":"Ann. Med."},{"issue":"6","key":"10.1016\/bs.acc.2022.03.001_bb0635","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.blre.2016.05.002","article-title":"The contribution of different adipose tissue depots to plasma plasminogen activator inhibitor-1 (PAI-1) levels","volume":"30","author":"Barnard","year":"2016","journal-title":"Blood Rev."},{"key":"10.1016\/bs.acc.2022.03.001_bb0640","doi-asserted-by":"crossref","first-page":"110","DOI":"10.5604\/01.3001.0010.3795","article-title":"The role of chemerin in human disease","volume":"71","author":"Stojek","year":"2017","journal-title":"Postepy Hig. Med. Dosw. (Online)"},{"key":"10.1016\/bs.acc.2022.03.001_bb0645","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cca.2021.02.010","article-title":"Chemerin in inflammatory diseases","volume":"517","author":"Su","year":"2021","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/bs.acc.2022.03.001_bb0650","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12020-011-9507-9","article-title":"Apelin, diabetes, and obesity","volume":"40","author":"Castan-Laurell","year":"2011","journal-title":"Endocrine"},{"issue":"3","key":"10.1016\/bs.acc.2022.03.001_bb0655","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1753-0407.2011.00132.x","article-title":"Apelin and insulin resistance: another arrow for the quiver?","volume":"3","author":"Xu","year":"2011","journal-title":"J. Diabetes"},{"issue":"10","key":"10.1016\/bs.acc.2022.03.001_bb0660","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1194\/jlr.R094060","article-title":"Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication","volume":"60","author":"Funcke","year":"2019","journal-title":"J. Lipid Res."},{"issue":"2","key":"10.1016\/bs.acc.2022.03.001_bb0665","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1586\/epr.12.12","article-title":"Angiopoietin-like protein 4: health effects, modulating agents and structure-function relationships","volume":"9","author":"Grootaert","year":"2012","journal-title":"Expert Rev. Proteomics"},{"issue":"3","key":"10.1016\/bs.acc.2022.03.001_bb0670","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jacl.2018.01.012","article-title":"Angiopoietin-like protein 4: a therapeutic target for triglycerides and coronary disease?","volume":"12","author":"Olshan","year":"2018","journal-title":"J. Clin. Lipidol."},{"issue":"12","key":"10.1016\/bs.acc.2022.03.001_bb0675","article-title":"Angiopoietin-like protein 3, an emerging cardiometabolic therapy target with systemic and cell-autonomous functions","volume":"1865","author":"Ruhanen","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/bs.acc.2022.03.001_bb0680","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.diabres.2017.08.025","article-title":"Angiopoietin-like protein 8: an attractive biomarker for the evaluation of subjects with insulin resistance and related disorders","volume":"133","author":"Wang","year":"2017","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"4","key":"10.1016\/bs.acc.2022.03.001_bb0685","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/CRD.0000000000000258","article-title":"Angiopoietin-like 3 protein inhibition: a new frontier in lipid-lowering treatment","volume":"27","author":"Lang","year":"2019","journal-title":"Cardiol. Rev."},{"issue":"6","key":"10.1016\/bs.acc.2022.03.001_bb0690","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/07853890903022801","article-title":"Increased plasma interleukin-1 receptor antagonist levels in men with visceral obesity","volume":"41","author":"Cartier","year":"2009","journal-title":"Ann. Med."},{"issue":"3","key":"10.1016\/bs.acc.2022.03.001_bb0695","doi-asserted-by":"crossref","first-page":"152","DOI":"10.4103\/0970-258X.288119","article-title":"Anti-interleukin-6 therapies for Covid-19: a systematic review, critical appraisal and meta-analysis","volume":"33","author":"Elavarasi","year":"2020","journal-title":"Natl Med. J. India"},{"key":"10.1016\/bs.acc.2022.03.001_bb0700","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102696","article-title":"Interleukin-6 inhibition with tocilizumab for relapsing MOG-IgG associated disorder (MOGAD): a case-series and review","volume":"48","author":"Elsbernd","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/bs.acc.2022.03.001_bb0705","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1472-6793-12-8","article-title":"Interleukin-1 beta: a potential link between stress and the development of visceral obesity","volume":"12","author":"Speaker","year":"2012","journal-title":"BMC Physiol."},{"issue":"6","key":"10.1016\/bs.acc.2022.03.001_bb0710","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1046\/j.1365-2796.1999.00490.x","article-title":"The role of TNFalpha and TNF receptors in obesity and insulin resistance","volume":"245","author":"Hotamisligil","year":"1999","journal-title":"J. Intern. Med."},{"issue":"2","key":"10.1016\/bs.acc.2022.03.001_bb0715","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1055\/s-0029-1212086","article-title":"Mechanisms of TNF-alpha-induced insulin resistance","volume":"107","author":"Hotamisligil","year":"1999","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"1","key":"10.1016\/bs.acc.2022.03.001_bb0720","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1006\/scdb.1998.0273","article-title":"The role of TNF alpha in adipocyte metabolism","volume":"10","author":"Sethi","year":"1999","journal-title":"Semin. Cell Dev. Biol."},{"issue":"60","key":"10.1016\/bs.acc.2022.03.001_bb0725","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001007","article-title":"The role of JNK proteins in metabolism","volume":"2","author":"Vallerie","year":"2010","journal-title":"Sci. Transl. Med."},{"issue":"10","key":"10.1016\/bs.acc.2022.03.001_bb0730","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11306-019-1599-x","article-title":"Metabolomics: a search for biomarkers of visceral fat and liver fat content","volume":"15","author":"Boone","year":"2019","journal-title":"Metabolomics"}],"container-title":["Advances in Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065242322000269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065242322000269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T12:59:32Z","timestamp":1753707572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065242322000269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9780323988513"],"references-count":145,"URL":"https:\/\/doi.org\/10.1016\/bs.acc.2022.03.001","relation":{},"ISSN":["0065-2423"],"issn-type":[{"value":"0065-2423","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]}}}